We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01745120
Brief Title: A Study Evaluating the Safety and Efficacy of the LentiGlobin® BB305 Drug Product in Beta-Thalassemia Major Subjects

First Submitted : December 6, 2012
First Submitted that Met QC Criteria : December 6, 2012
First Posted : December 7, 2012 (Estimate)

Last Update Submitted : December 14, 2017
Last Update Submitted that Met QC Criteria : December 14, 2017
Last Update Posted : December 18, 2017